Stratec SE (SBS.F)

41.25 +1.35 (+3.38%) As of 08:09AM CEST. Market open.

Stratec SE

Gewerbestrasse 37
Birkenfeld 75217
Germany
49 7082 7916 0
https://www.stratec.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 1,480

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Marcus Wolfinger	Chairman of Board of Management & CEO	1M	N/A	1967
Dr. Robert Siegle	Director of Finance & Human Resources and Member of Board of Management	769k	N/A	1967
Dr. Claus Vielsack	Director of Product Development & Member of Board of Management	619k	N/A	1967
Dr. Georg Bauer	Director for Sales & Member of Management Board	404k	N/A	1973
Mr. Hermann Leistner	Founder & Advisor	N/A	N/A	1946
Mr. Jan Keppeler	Head of Investor Relations, Sustainability & Corporate Communications	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Corporate Governance

Stratec SE’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.